TORONTO, Aug. 11, 2016 /CNW/ – CannTrust™ Inc., the country’s only pharmacist controlled and operated producer of pharmaceutical-grade Medical Cannabis, is pleased to announce the appointment of Aubrey Dan as Chairman of the Board and Brad Rogers as President and COO.
Mr. Dan and Mr. Rogers bring tremendous pharmaceutical and health care expertise, and will immediately aid CannTrust in its patient-centric mission to improve health outcomes, and access to safe, standardized, high quality Medical Cannabis. This approach, and a unique commitment to innovation, has driven CannTrust to invest in a state-of-the-art 40,000 square foot hydroponic facility, and to develop better, controlled dosage forms like the patented CANNCUP™ pods which produce single servings of coffee, tea or hot chocolate containing specifically prescribed quantities of cannabis.
“From the start, CannTrust has been singularly focused on the therapeutic benefits of Cannabis,” says Eric Paul, CEO of CannTrust Inc. and a pharmacist. “Aubrey’s expertise and experience in the Generic Pharmaceutical sector combined with Brad’s marketing vision and consumer insights will help CannTrust achieve long-term sustained growth as we work to pharmaceuticalize Cannabis for Canadian patients.”
Aubrey Dan — Chairman of the Board
Mr. Dan is a renowned business leader, Tony-Award® winning producer and philanthropist who will apply a deep understanding of the Canadian health-care system to help position CannTrust™ as the provider of medical cannabis that is focused on patients and therapeutic outcomes.
A graduate of Western University, Mr. Dan started his career as Director of Sales for Novopharm Limited, his father’s company, and was subsequently named President of Wampole, a vitamin and over-the-counter (OTC) manufacturer. It was during the five years that Mr. Dan was at the helm that Wampole established itself as a significant player in the herbal products category and more than doubled sales.
“There are incredible correlations between manufacturing generic pharmaceuticals and OTCs and the production of Medical Cannabis,” explains Mr. Dan. “Innovative, research-based approaches to health care that are based on what consumers need, provide incredible value to patients and payers alike. I look forward to working with the CannTrust team; adding value as it navigates the changing Medical Marijuana landscape, while helping to shape the vision of the company.”
In 2002, Mr. Dan founded Dancap Private Equity, a private firm that invests its own funds in mid-market Canadian and international businesses. Mr. Dan has also gained fame as a Tony Award winning theatre producer. He has presented over 25 shows in Toronto and Produced the Canadian production of Jersey Boys which ran for more than two years and was attended by 1.2 million people.
Mr. Dan and his wife Marla are active philanthropists who contribute to a number of health, children’s and educational charities such as Sunnybrook Hospital where The Aubrey & Marla Dan Program for High Risk Mothers and Babies is named in their honour.
Brad Rogers — President and COO
Mr. Rogers is a recognized expert in the business of Medical Cannabis production and a creative brand-building marketer. He will apply his talent towards establishing CannTrust’s role in the health-care system as Canada’s most trusted provider of Medical Cannabis. Known for building high performing teams, Mr. Rogers is responsible for the planning and execution of brand-growth strategies to ensure valued CannTrust customers receive the very best products and support.
“Having spent the past three years working in Medical Cannabis, I am incredibly proud to be taking on this new role with CannTrust,” says Rogers. “This is a company of health-care and sector-specific experts who are doing it the right way: zeroing in on health benefits and helping patients achieve a better quality of life through research based treatment. As President and COO, I look forward to building on this solid foundation and applying the cross functional knowledge I’ve gained throughout the past 15 years.”
Prior to joining CannTrust, Mr. Rogers gained extensive experience in Medical Cannabis as one of the Founders of Mettrum, one of Canada’s largest MMPR (Marihuana for Medical Purposes Regulations) licensed companies. Serving as Mettrum’s Chief Operation Officer, he was responsible for stewarding the company through its initial MMPR application through to a go-public transaction on the TSX Venture Exchange.
Mr. Rogers received an Executive MBA degree from the Richard Ivey School of Business at Western University in 2011.
Federally licensed and regulated, CannTrust™ brings more than 40 years of pharmacy and health-care experience to the Medical Cannabis industry and applies this expertise to produce quality pharmaceutical-grade medical cannabis for patients in need. Based in Vaughan, Ontario, CannTrust is committed to producing the highest quality pharmaceutical grade cannabis; promoting evidence-based clinical research; and providing exceptional customer support. CannTrust has invested in its state-of-art hydroponic facility and onsite laboratory equipped with leading-edge technology, and has an exceptional team of pharmacists, nurses, scientists, laboratory technicians, master growers and call centre specialists.
With patient access as the focus, the company also provides the most comprehensive Patient Assistance Program for patients with financial needs in Canada. In addition, the CannTrust team of nurses, ND’s and pharmacists are available to answer patient questions and recommend the best strains to treat specific conditions.
For more information, visit CannTrust at www.canntrust.ca or call 1‑855‑RX4‑CANN (794-2266).
SOURCE CannTrust Inc
Image with caption: “Aubrey Dan, Eric Paul and Brad Rogers at CannTrust’s Vaughan headquarters (CNW Group/CannTrust Inc)”. Image available at: http://photos.newswire.ca/images/download/20160811_C4064_PHOTO_EN_751168.jpg
For further information: or to arrange an interview, please contact: Robyn Rabinovich, CannTrust, 1-855-794-2266 ext 2407, RRabinovich@canntrust.ca